Corcept Therapeutics, Inc. (CORT)
87.13
+1.82
(+2.13%)
USD |
NASDAQ |
Dec 11, 16:00
87.95
+0.82
(+0.94%)
After-Hours: 20:00
Corcept Therapeutics Cash from Investing (Quarterly): 14.64M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -414.00M |
| Gilead Sciences, Inc. | -427.00M |
| LeMaitre Vascular, Inc. | -27.45M |
| United Therapeutics Corp. | 140.90M |
| Vertex Pharmaceuticals, Inc. | -117.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 54.48M |
| Cash from Financing (Quarterly) | -46.41M |
| Free Cash Flow | 162.57M |
| Free Cash Flow Per Share (Quarterly) | 0.4561 |
| Free Cash Flow to Equity (Quarterly) | 54.73M |
| Free Cash Flow to Firm (Quarterly) | 54.48M |
| Free Cash Flow Yield | 1.56% |